Evidence map›Paper›PMID 20520640›Full record

ArticleLeukemia2010

Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism.

R A Hamoudi, A Appert, H Ye, A Ruskone-Fourmestraux, B Streubel, A Chott, M Raderer, L Gong, I Wlodarska, C De Wolf-Peeters and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Transcriptome Profiling Associated withInternational journal of molecular sciences · 2024
    Article
  14. Review
  15. Sustained exposure to Helicobacter pylori induces immune tolerance by desensitizing TLR6.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 4 countries.

R A HamoudiDepartment of Pathology, University of Cambridge, Cambridge, UK.
A Appert
H Ye
A Ruskone-Fourmestraux
B Streubel
A Chott
M Raderer
L Gong
I Wlodarska
C De Wolf-Peeters
K A MacLennan
L de Leval
P G Isaacson
M-Q Du
University of Cambridge · GBKU Leuven · BEMedical University of Vienna · ATCentre Hospitalier Universitaire de Liège · BEGroupe d'Étude des Méthodes de l'Analyse Sociologique de la Sorbonne · FRSt James's University Hospital · GBUniversity College London · GBVienna General Hospital · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucosa-associated lymphoid tissue (MALT) lymphoma is characterized by t(11;18)(q21;q21)/API2-MALT1, t(1;14)(p22;q32)/BCL10-IGH and t(14;18)(q32;q21)/IGH-MALT1, which commonly activate the nuclear factor (NF)-kappaB pathway. Gastric MALT lymphomas harboring such translocations usually do not respond to Helicobacter pylori eradication, while most of those without translocation can be cured by antibiotics. To understand the molecular mechanism of these different MALT lymphoma subgroups, we performed gene expression profiling analysis of 21 MALT lymphomas (13 translocation-positive, 8 translocation-negative). Gene set enrichment analysis (GSEA) of the NF-kappaB target genes and 4394 additional gene sets covering various cellular pathways, biological processes and molecular functions have shown that translocation-positive MALT lymphomas are characterized by an enhanced expression of NF-kappaB target genes, particularly toll like receptor (TLR)6, chemokine, CC motif, receptor (CCR)2, cluster of differentiation (CD)69 and B-cell CLL/lymphoma (BCL)2, while translocation-negative cases were featured by active inflammatory and immune responses, such as interleukin-8, CD86, CD28 and inducible T-cell costimulator (ICOS). Separate analyses of the genes differentially expressed between translocation-positive and -negative cases and measurement of gene ontology term in these differentially expressed genes by hypergeometric test reinforced the above findings by GSEA. Finally, expression of TLR6, in the presence of TLR2, enhanced both API2-MALT1 and BCL10-mediated NF-kappaB activation in vitro. Our findings provide novel insights into the molecular mechanism of MALT lymphomas with and without translocation, potentially explaining their different clinical behaviors.

Indexed as

Translocation, GeneticAdaptor Proteins, Signal TransducingB-Cell CLL-Lymphoma 10 ProteinGene Expression ProfilingHumansImmunohistochemistryLymphoma, B-Cell, Marginal ZoneNF-kappa BOligonucleotide Array Sequence AnalysisOncogene Proteins, FusionReverse Transcriptase Polymerase Chain ReactionToll-Like Receptor 6Adaptor Proteins, Signal TransducingAPI2-MALT1 fusion protein, humanB-Cell CLL-Lymphoma 10 ProteinBCL10 protein, humanNF-kappa BOncogene Proteins, FusionTLR6 protein, humanToll-Like Receptor 6

Identifiers

PMID20520640
OpenAlexW1990762111

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.